First human DNA vaccine First in class thermostable self-amplifying mRNA vaccine GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges ...

PharmaTher Holdings PHRRF, the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study ...

PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...

In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory ...

Intradermal administration of the JYNNEOS mpox vaccine is as effective and safe as subcutaneous administration, according to new data released this week by the Centers for Disease Control and ...

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference PharmaJet will deliver two presentations on ...

The following two articles on controllable self-replicating RNA vaccines form part of a broader series on next-generation mRNA vaccines. The first three installments can be read here, here, and here, ...

With many in the gay community clamoring for the monkeypox vaccine this summer, hoping for protection from a virus that causes painful and gruesome lesions, the United States faced a challenge. “The ...

Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it secured $100 million in Series C funding. Alpha Wave Ventures led the ...

A Rutgers Health survey of LGBTQ+ individuals in New York and New Jersey reveals that cisgender men, gay individuals and full-time employees had the highest rates of vaccination for Mpox, a viral ...